Top-Ranked Horizon Therapeutics Hits Key RS Rating Benchmark

Top-Ranked Horizon Therapeutics Hits Key RS Rating Benchmark

Horizon Therapeutics is showing rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82.